IE37835L - Pharmaceutical compositions containing pyrazolone¹derivatives - Google Patents

Pharmaceutical compositions containing pyrazolone¹derivatives

Info

Publication number
IE37835L
IE37835L IE731036A IE103673A IE37835L IE 37835 L IE37835 L IE 37835L IE 731036 A IE731036 A IE 731036A IE 103673 A IE103673 A IE 103673A IE 37835 L IE37835 L IE 37835L
Authority
IE
Ireland
Prior art keywords
amino
pyrazol
alkyl
diluent
admixture
Prior art date
Application number
IE731036A
Other versions
IE37835B1 (en
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IE37835L publication Critical patent/IE37835L/en
Publication of IE37835B1 publication Critical patent/IE37835B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/44—Oxygen and nitrogen or sulfur and nitrogen atoms
    • C07D231/52—Oxygen atom in position 3 and nitrogen atom in position 5, or vice versa

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1391052 Pyrazolone derivatives BAYER AG 22 June 1973 [23 June 1972] 29786/73 Heading A5B A pharmaceutical composition contains as an active ingredient a compound which is a 3-amino-pyrazol-5-one of general formula: or its salt in which R is an aryl radical which carries either no substituents or the following substituents, (a) 1, 2 or 3 identical or different substituents selected from halogen, trifluoromethyl, alkyl, phenyl, alkoxy, and alkenoxy groups; or (b) one alkylamino, dialkylamino, trifluoromethoxy, nitro, nitrile, carbonamido, sulphonamido or SO n -Alkyl (n=0, 1 or 2) group and optionally also 1 or 2 substituents selected from alkyl, alkoxy, halogen and trifluoromethyl groups; or (c) an annellated branched or unbranched, saturated or unsaturated 5-, 6- or 7-membered-isocyclic or heterocyclic ring (which latter ring can optionally contain 1 or 2 oxygen andlor sulphur atoms) in admixture with a solid or liquefied gaseous diluent or in admixture with a liquid diluent other than a solvent of a molecular weight less than 200 except in the presence of a surface active agent. The active ingredient may be in the form of its sodium, potassium, ethanolamine, diethanolamine, triethanolamine, amino-tris-hydroxymethyl-methane, glucosamine or N-methyl-glucosamine salt. The compound may be used in the form of a sterile or isotonic solution. It may also be used with or without a diluent, as a medicament and in the form of tablets, pills, dragees, capsules, ampoules or suppositories. Suitable compounds exemplified are 3-aminol-(4-chlorobenzyl)-pyrazole- 5 - one, 3-amino- 1-(4-bromobenzyl)-pyrazol-5-one and 3-amino- 1-(3, 4-dimethylbenzyl)-pyrazol-5-one. [GB1391052A]
IE1036/73A 1972-06-23 1973-06-22 Medicinal use of pyrazolone derivatives IE37835B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2230675A DE2230675A1 (en) 1972-06-23 1972-06-23 DIURETIC AND ANTIHYPERTENSIVE AGENT

Publications (2)

Publication Number Publication Date
IE37835L true IE37835L (en) 1973-12-23
IE37835B1 IE37835B1 (en) 1977-10-26

Family

ID=5848526

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1036/73A IE37835B1 (en) 1972-06-23 1973-06-22 Medicinal use of pyrazolone derivatives

Country Status (9)

Country Link
BE (1) BE801227A (en)
DE (1) DE2230675A1 (en)
FR (1) FR2189071B1 (en)
GB (1) GB1391052A (en)
IE (1) IE37835B1 (en)
IL (1) IL42562A (en)
LU (1) LU67748A1 (en)
NL (1) NL7308648A (en)
ZA (1) ZA734240B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2319278C2 (en) * 1973-04-17 1986-02-20 Bayer Ag, 5090 Leverkusen Pharmaceutical agent
USRE30420E (en) * 1973-04-17 1980-10-21 Bayer Aktiengesellschaft Pyrazol-5-ones
US4081596A (en) * 1973-04-17 1978-03-28 Bayer Aktiengesellschaft Pyrazol-5-ones

Also Published As

Publication number Publication date
ZA734240B (en) 1974-05-29
GB1391052A (en) 1975-04-16
FR2189071B1 (en) 1977-09-09
IL42562A0 (en) 1973-08-29
IL42562A (en) 1977-05-31
IE37835B1 (en) 1977-10-26
AU5720073A (en) 1975-01-09
BE801227A (en) 1973-12-21
FR2189071A1 (en) 1974-01-25
LU67748A1 (en) 1973-08-16
NL7308648A (en) 1973-12-27
DE2230675A1 (en) 1974-01-10

Similar Documents

Publication Publication Date Title
ES2082805T3 (en) DERIVATIVES OF TIAZOL, PROCEDURES FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THE SAME.
FI891176A0 (en) PEPTIDFOERENINGAR, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DESSA INNEHAOLLANDE PHARMACEUTISKA BLANDNINGAR.
DE3854454D1 (en) Pyrazolopyridine compounds and process for their preparation.
NO863980D0 (en) PROCEDURE FOR THE PREPARATION OF CHINAZOLINE DERIVATIVES.
AU3607895A (en) 1-acyl-4-aliphatylaminopiperidine compounds
IL74031A0 (en) Cyanoguanidinophenyldihydropyridazinone derivatives,their preparation and pharmaceutical compositions containing them
IE38730B1 (en) Heterocyclic containing sulphoxides
HUT43051A (en) Process for preparing pyridine-carboxylic acid derivatives and pharmaceutical compositions containing thereof as active ingredients
ES488656A1 (en) N-substituted 2-cyanaziridines, methods for their preparation and medicaments containing them, correspondingly substituted aziridine-2-carbonamides and their preparation.
MY101801A (en) Novel phenoxyacetic acid derivatives, process for preparing the same and pharmaceutical composition having the same as an active ingredient.
ES8103053A1 (en) 2-Imidazoline derivatives, process for the preparation thereof and the pharmaceutical composition of the same.
ES8500232A1 (en) Aromatic compounds.
ES2116467T3 (en) DERIVATIVES OF 5H, 10H-IMIDAZO (1,2-A) INDENO (1,2-E) PIRAZINA-4-ONA, ITS PREPARATION AND THE MEDICINES CONTAINING THEM.
IE37835L (en) Pharmaceutical compositions containing pyrazolone¹derivatives
IE39212L (en) Substituted pyrazolones
GB1055221A (en) Pyridobenzoxazepine derivatives
ES8503347A1 (en) Piperidine-3-carboxylic acid derivatives, process for their preparation, and pharmaceutical compositions containing them.
ES8609322A1 (en) Imidazoquinoline derivatives.
ES8801794A1 (en) 5-Aryl-dihydropyridines, process for their preparation as well as use in medicaments.
GB1395451A (en) Diphenyl ether derivatives
GB1199857A (en) o-Substituted 2-Phenylimino-1-Azacycloheptanes and their production
JPS52254A (en) Process for preparation of secopenicilanic acid amide derivatives
DK210387D0 (en) HETEROCYCLIC RELATIONS AND PROCEDURES FOR THEIR PREPARATION AND PHARMACEUTICAL AGENTS CONTAINING THESE
GB1061766A (en) A process for preparing 2-alkoxycycloheptimidazole derivatives
GB973142A (en) (4-acetyl-1-naphthoxy) propyl esters